Norway · Delayed Price · Currency is NOK Tekna Holding ASA Earnings Call Transcripts
Fiscal Year 2026
-
Q2 revenue rose 18% year-over-year to CAD 10.6 million, with strong growth in both materials and systems. Adjusted EBITDA turned positive for the fourth consecutive quarter, and order intake more than doubled, driving a record backlog. Margins and cash position remain robust, with continued momentum in aerospace, defense, and medical sectors.
-
Q1 saw 19% year-over-year revenue growth, third consecutive positive adjusted EBITDA, and strong margins in both Materials and Systems. Robust backlog, new customer wins in defense and medical, and a solid balance sheet support double-digit growth ambitions.
Fiscal Year 2025
-
Q4 marked a profitability milestone with record EBITDA and strong materials business growth, supported by robust order intake and margin expansion. The balance sheet was transformed by a major equity raise, positioning the company for continued double-digit growth and strategic flexibility.
-
Achieved first profitable quarter since IPO, with revenues up 9% and materials revenue up 28% year-over-year. Post-rights issue, the company will be net cash positive and well-positioned for double-digit growth, driven by strong demand in aerospace and additive manufacturing.
-
A fully underwritten NOK 300 million rights issue and new credit facilities will transform the balance sheet to a net cash position, supporting profitable growth. Q3 saw positive EBITDA, strong margin expansion, and ongoing cost reductions, with double-digit growth targeted through 2030.
Fiscal Year 2024
-
Q4 revenue fell 15% year-over-year due to lower systems sales, but advanced materials grew 14%, with strong gains in aerospace and medical. Cost reductions, improved cash flow, and a legal win strengthened financials, while 2025 is expected to bring higher revenue and margins.
-
Q3 2024 revenue declined 16% year-over-year, mainly due to a sharp drop in system segment sales, but Advanced Materials sales rose 5%. Cost-saving measures improved adjusted EBITDA, and the company maintains a strong long-term growth outlook, targeting CAD 70 million in revenue by 2027.
-
Q2 2024 saw a 2% year-over-year revenue increase and a 35% sequential rebound in materials, but Adjusted EBITDA remained negative. Cost reduction and working capital initiatives are expected to yield CAD 2 million in annual savings, with a strong systems pipeline for H2.